Dr Elizaveta Olkhova

Research Fellow

Key Publications

Please visit the Pure Research Information Portal for further information
MyD88 deficiency modestly attenuates disease in a Leigh syndrome mouse model while enrofloxacin accelerates disease, Hanaford, A., Olkhova, E., Liao, R., Ching, A., Huang, A., Hsieh, E., Watanabe, K., Chen, Y., Wichman, M., Hwang, N., James, K., Mulholland, M., Truong, V., Coulson, H., Gibbins, K., Cairns, O., Dimitriou, A., Kayser, E., Johnson, B., Sarkar, S., Kalia, V., Johnson, S. 16 Sep 2026, In: Journal of Neuropathology and Experimental Neurology
Neuroinflammation in epilepsy: Mitochondrial connections and therapeutic targets, Olkhova, E., Dimitriou, A., Johnson, B., Hanaford, A., Johnson, S. 1 Apr 2026, In: Brain Mechanisms
Delineating the mechanisms of cerebellar degeneration in paediatric and adult primary mitochondrial disease, Smith, L., Olkhova, E., Lax, N., Ng, Y., Taylor, R., Gorman, G., Erskine, D., McFarland, R. 30 May 2025, In: Acta Neuropathologica
Evaluating the efficacy of vatiquinone in preclinical models of Leigh syndrome and GPX4 deficiency, Kayser, E., Mulholland, M., Olkhova, E., Chen, Y., Coulson, H., Cairns, O., Truong, V., James, K., Johnson, B., Hanaford, A., Johnson, S. 10 Feb 2025, In: Orphanet Journal of Rare Diseases

Qualifications

PhD July 21 2022